Received Apr 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EW0172 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EW018 | IM / AR |
PFIZER #1 7/26/2021 PFIZER #2 8/16/2021 SUFFERED VACCINE FAILURE AND CONTRACTED COVID-19. FELT GENERALLY UNWELL AFTER THAT WITH POST-EXERTIONAL MALAISE, FATIGUE, LOSS OF MENTAL CLARITY. IN 2024 WAS HOSPITALIZED THREE TIMES FOR SOB AND ON THE THIRD ADMISSION WAS FOUND TO HAVE COVID-19 VACCINE INDUCED MULTIPLE PE AND A LEFT LEG UNPROVOKED DVT. GENETIC EVALUATION FOR THROMBOPHILIA WAS NEGATIVE. ALSO DEVELOPED AN EXPANDING THORACIC AORTIC ANEURYSM. 2026 SPIKE ABS 19,306. TREATED WITH PROTOCOL BASE SPIKE DETOXIFICATION. Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes. Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination.
CAD SP STENT, HYPOTHYROIDISM, HTN, PROSTATE CANCER SP RADICAL PROCTECTOMY FOR CURE
CAD SP STENT, HYPOTHYROIDISM, HTN, PROSTATE CANCER SP RADICAL PROCTECTOMY FOR CURE
LEVOTHYROXINE, LISINOPRIL, CARVEDILOL, ROSUVASTATIN
NKDA
ECG, EXAM, ECHOCARDIOGRAPHY, CHEST CT, LABS